Senior Health Channel
Topics & Medications
Related Channels

Menomune Uses

Menomune helps protect against bacterial meningitis, certain bloodstream infections, and other diseases caused by Neisseria meningitidis bacteria. Because a newer meningococcal vaccine is available (Menactra), Menomune is generally only recommended when Menactra is unavailable. In some cases, healthcare providers will use Menomune for "off-label" purposes, such as for children under the age of two in the event of an outbreak.

What Is Menomune Used For?

Menomune® (meningococcal vaccine) is approved to provide protection against invasive meningococcal disease in people age two and older. Invasive meningococcal diseases include:
  • Bloodstream infections
  • Bacterial meningitis (a bacterial infection of the fluid surrounding the brain and spinal cord).
It is used only to prevent meningococcal disease caused by Neisseria meningitidis; it does not provide protection against any other types of bacteria.
Invasive meningococcal diseases are quite serious, even if they are treated appropriately with antibiotics. For instance, as many as 10 to 15 percent of people treated with antibiotics for bacterial meningitis will die. Of those that survive, 11 to 19 percent have serious and sometimes devastating complications, such as loss of an arm or leg, deafness, seizures, strokes, or mental retardation. This is why it is so important to prevent invasive meningococcal diseases.
Menomune is used in individuals age two and older. However, the Centers for Disease Control (CDC) recommends the use of a newer meningococcal vaccine (Menactra®) for individuals 2 though 55 years of age. Currently, Menomune is recommended only for adults over the age of 55 or for other age ranges if Menactra is unavailable.
In addition, routine vaccination against meningococcal diseases is recommended only for the following groups:
  • Almost all children and adolescents between 11 and 18 years of age
  • College freshmen living in dormitories
  • Laboratory workers who are routinely exposed to N. meningitidis
  • United States military recruits
  • Anyone living in or traveling to areas of the world where meningococcal disease is common
  • Anyone with a damaged or removed spleen
  • People with a specific immune system disorder known as "terminal complement component deficiency"
  • People who might have been exposed to meningitis during an outbreak.
The Top 17 Side Effects of Chemotherapy

Menomune Vaccine Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.